Ozempic, Wegovy and Mounjaro are among the weight-loss drugs that more people are taking - but questions have been raised about their economic impacts.
These drugs will also have an impact on other sectors, including healthcare and food, and research is still ongoing.
Fisher Funds expert Sam Dickie explained further.
LISTEN ABOVE

Katherine Rich: BusinessNZ CEO on the impact NZ First's proposed tax cut for small and medium businesses could have
09:03

Kerre Woodham: Are these election promises worth it to you?
04:37

Campbell Parker: DairyNZ CEO on Fonterra's positive annual result
02:16